Biopharma Business

Tag "Pharmacovigilance Risk Assessment Committee"

EMA to Evaluate Liver Problems Linked to Zinbryta

    EMA to Evaluate Liver Problems Linked to Zinbryta

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) discussed the safety reviews of a variety of medications during its June 2017 meeting. The medicines in review included treatments for

Read Full Article

EMA Launch of New EudraVigilance System Moves Forward

    EMA Launch of New EudraVigilance System Moves Forward

On May 22, 2017, the European Medicines Agency (EMA) announced that its Pharmacovigilance Risk Assessment Committee has completed an audit and evaluation of the new EudraVigilance information system for tracking

Read Full Article

Upcoming Events

  • No upcoming events
AEC v1.0.4

The Magazine

New Subscriber

Subscribe Here



Advertisements